Stay updated on Bladder Cancer Combo Clinical Trial
Sign up to get notified when there's something new on the Bladder Cancer Combo Clinical Trial page.

Latest updates to the Bladder Cancer Combo Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed study information regarding pembrolizumab therapy for high-risk non-muscle-invasive bladder cancer, while adding new registry identifiers and a revision number.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.2%
- Check45 days agoChange DetectedThe webpage has undergone significant updates, including the removal of specific outcome measures for Cohort C and the addition of new details regarding the exploratory nature of Cohort C. Additionally, new study numbers and metrics for Cohorts A and B have been introduced.SummaryDifference13%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Bladder Cancer Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bladder Cancer Combo Clinical Trial page.